文献速递主动脉疾病颈动脉与弓上血管外周动脉疾病

严重动脉粥样硬化与广泛性动脉瘤患者血清KLF4水平升高

Increased Serum KLF4 in Severe Atheromatosis and Extensive Aneurysmal Disease.
PubMed 文献 · Ann Vasc Surg · 2020-05-01

本研究纳入因动脉粥样硬化或动脉瘤手术的患者,检测血清KLF4水平。结果发现动脉粥样硬化和动脉瘤组血清KLF4均显著高于对照组,且伴有终末器官损害的动脉粥样硬化患者及广泛性动脉瘤患者KLF4水平更高。

要点

  • 动脉粥样硬化及动脉瘤患者血清KLF4水平显著高于对照组。
  • 动脉粥样硬化伴终末器官损害者KLF4高于无症状颈动脉狭窄或跛行患者。
  • 广泛性动脉瘤患者血清KLF4水平显著升高。

核心结论

  • 血清KLF4水平在动脉粥样硬化相关终末器官损害及广泛性动脉瘤患者中显著升高。

研究设计与样本

  • 纳入因各种形式动脉粥样硬化或动脉瘤修复手术的患者,采用酶联免疫吸附试验测定血清KLF4水平。

主要发现

  • 动脉粥样硬化组和动脉瘤组血清KLF4水平显著高于对照组。
  • 动脉粥样硬化伴终末器官损害组(ATH3)血清KLF4为6.96 ± 0.75 pg/mL,高于无症状颈动脉狭窄>70%或跛行组(ATH1)的2.76 ± 0.68 pg/mL(平均差-4.20,95%CI -5.35至-3.04,P<0.01)及短暂性脑缺血发作或静息痛组(ATH2)的4.47 ± 1.08 pg/mL(平均差-2.48,95%CI -3.76至-1.21)。
  • 无症状动脉瘤直径250-300%正常动脉组(AA1)血清KLF4为5.01 ± 1.08 pg/mL,低于症状性动脉瘤或无症状动脉瘤直径>350%正常动脉组(AA3)的6.63 ± 1.92 pg/mL(平均差-2.61,95%CI -5.04至-0.18,P<0.01)。

临床怎么用

  • 血清KLF4可能作为评估动脉粥样硬化严重程度及动脉瘤范围的潜在生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Krüppel-like factor 4 (KLF4) is known to preserve vascular homeostasis. In the present study, we sought to correlate serum KLF4 levels with arterial aneurysm size and their clinical presentation. We also explored the association between serum KLF4 levels and the severity of extracranial carotid and peripheral arterial disease. METHODS: Patients undergoing surgery for various forms of atheromatosis (ATH group) or for arterial aneurysm repair (AA group) were eligible for inclusion. KLF4 levels were measured via enzyme-linked immunosorbent assay. RESULTS: Patients in the atheromatic and aneurysmal groups had significantly higher serum KLF4 levels compared with controls. Patients with permanent end-organ damage (ATH3) had higher serum KLF4 (6.96 ± 0.75 pg/mL) compared with patients with asymptomatic internal carotid stenosis >70% or claudication (ATH1) (2.76 ± 0.68 pg/mL; mean difference [MD], -4.20; 95% confidence interval [95% CI], -5.35 to -3.04; P < 0.01) and those with transient ischemic attack or rest pain (ATH2) (4.47 ± 1.08 pg/mL; MD, -2.48; 95% CI, -3.76 to -1.21). Furthermore, patients with an asymptomatic aneurysm of a diameter 250-300% of that of the normal artery (AA1, 5.01 ± 1.08 pg/mL) had considerably lower serum KLF4 compared with those suffering from either a symptomatic aneurysm or an asymptomatic aneurysm of a diameter >350% of that of normal artery (AA3, 6.63 ± 1.92 pg/mL; MD, -2.61; 95% CI, -5.04 to -0.18; P < 0.01). CONCLUSIONS: Serum KLF4 levels are significantly increased in patients with end-organ damage related to atheromatosis as well as those with extensive aneurysmal disease.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bakoyiannis C, Mylonas KS, Papoutsis K, et al. Increased Serum KLF4 in Severe Atheromatosis and Extensive Aneurysmal Disease. Ann Vasc Surg. 2020. PMID: 32360698. doi:10.1016/j.avsg.2020.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。